Patent foramen ovale and migraine: A cross-sectional study from the Northern Manhattan Study (NOMAS)

Circulation

Volumn 118, Issue 14, 2008, Pages 1419-1424

  Rundek, Tatjana ^a   Elkind, Mitchell S V ^b   Di Tullio, Marco R ^b   Carrera, Emmanuel ^b   Jin, Zhezhen ^c   Sacco, Ralph L ^a   Homma, Shunichi ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^c Mailman School of Public Health   (United States)

Author keywords

Echocardiography; Epidemiology; Foramen ovale, patent; Migraine disorders; Risk factors

Indexed keywords

SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATENT FORAMEN OVALE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SELF REPORT; TRANSTHORACIC ECHOCARDIOGRAPHY; URBAN AREA; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; METHODOLOGY; MIDDLE AGED; RISK FACTOR; UNITED STATES;

AGED; AGED, 80 AND OVER; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; FORAMEN OVALE, PATENT; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NEW YORK CITY; RISK FACTORS;

EID: 54049120091     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.771303     Document Type: Article

References (36)

1. Goadsby PJ, Lipton RB, Ferrari MD. Migraine: current understanding and treatment. N Engl J Med. 2002;346:257-270.
2. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain, 2nd edition. Cephalalgia. 2004;24: 1-160.
3. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology. 1999;53:537-542.
4. Menken M, Munsat TL, Toole JF. The Global Burden of Disease Study: implications for neurology. Arch Neurol. 2000;57:418-420.
5. Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. JAm Coll Cardiol. 2007;49:797-802.
6. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59:17-20.
7. Meissner I, Whisnant JP, Khanderia BK, Spittell PC, O'Fallon WM, Pascoe RD, Enriquez-Sarano M, Seward JB, Covalt JL, Sicks JD, Wiebers DO. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc. 1999;74:862-869.
8. Schwerzmann M, Nedeltchev K, Lagger F, Mattle HP, Windecker S, Meier B, Seiler C. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology. 2005;65:1415-1418.
9. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology. 1999;52:1622-1625.
10. Del Sette M, Angeli S, Leandri M, Ferriero G, Bruzzone GL, Finocchi C, Gandolfo C. Migraine with aura and right-to-left shunt on transcranial Doppler: a case control study. Cerebrovasc Dis. 1998;8:327-330.
11. Domitrz I, Mieszkowski J, Kamińska A. Relationship between migraine and patent foramen ovale: a study of 121 patients with migraine. Headache. 2007;47:1311-1318.
12. Ferrari G, Malferrari G, Zucco R, Gaddi O, Norina M, Pini LA. High prevalence of patent foramen ovale in migraine with aura. J Headache Pain. 2005;6:71-76.
13. Buzzi MG, Moskowitz MA. The pathophysiology of migraine: year 2005. J Headache Pain. 2005;6:105-111.
14. Schwedt TJ, Dodick DW. Patent foramen ovale and migraine: bringing closure to the subject. Headache. 2006;46:663-671.
15. Wilmshurst PT, Pearson MJ, Nightingale S, Walsh KP, Morrison WL. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart. 2004;90:1315-1320.
16. Bigal ME, Liberman JN, Lipton RB. Age-dependent prevalence and clinical features of migraine. Neurology. 2006;67:246-251.
17. Wilmshurst P, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet. 2000;356:1648-1651.
18. Post M, Thijs V, Herroelen L, Budts W. Closure of patent ovale is associated with decrease in prevalence of migraine. Neurology. 2004;62: 1439-1440.
19. Schwerzmann M, Wiher S, Nedeltchev K, Mattle HP, Wahl A, Seiler C. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology. 2004;62:1399-1401.
20. Riederer F, Kaya M, Christina P, Harald G, Peter W. Migraine with aura related to closure of atrial septal defects. Headache. 2005;45:953-956.
21. Anzola GP, Frisoni GB, Morandi E, Casilli F, Onorato E. Shunt-associated migraine responds favorably to atrial septal repair. Stroke. 2006;37:430-434.
22. Reisman M, Christofferson RD, Jerusum J, Olsen JV, Spencer MP, Krabill KA, Diehl L, Aurora S, Gray WA. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol. 2005; 45:493-495.
23. Dowson A, Mullen MJ, Peatfield R, Muir K, Anis Khan A, Wells C, Lipscombe SL, Rees T, De Giovanni JV, Morrison WL, Hildick-Smith D, Elrington G, Hillis WS, Iqbal S, Malik IS, Rickards A. Migraine Intervention With STARFlex Technology (MIST) Trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008;117:1397-1404.
24. Diener HC, Kurth T, Dodick D. Patent foramen ovale and migraine. Curr Pain Headache Rep. 2007;11:236-240.
25. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP; for the PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale in Cryptogenic Stroke Study. Circulation. 2002;105:2625-2631.
26. Sacco RL, Anand K, Lee HS, Boden-Albala B, Stabler S, Allen R, Paik MC. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the Northern Manhattan Study. Stroke. 2004;35:2263-2269.
27. White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, Sacco RL. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation. 2005;111: 1327-1331.
28. Gentry EM, Kalsbeek WD, Hogelin GC, Jones JT, Gaines KL, Forman MR, Marks JS, Trowbridge FL. The Behavioral Risk Factor Surveys, II: design, methods, and estimates from combined state data. Am J Prev Med. 1985;1:9-14.
29. Office of Management and Budget. Race and ethnic standards for federal statistics and administrative reporting (Directive No. 15). Fed Reg. 1978; 43:19269.
30. Sacco RL, Gan R, Boden-Albala B, Lin IF, Kargman DE, Hauser WA, Shea S, Paik MC. Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke. 1998;29:380-387.
31. Dalla Volta G, Guindani M, Zavarise P, Griffini S, Pezzini A, Padovani A. Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain. 2005;6:328-330.
32. Mortelmans K, Post M, Thijs V, Herroelen L, Budts W. The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur Heart J. 2005;26:1533-1537.
33. Carod-Artal FJ, da Silveira Ribeiro L, Braga H, Kummer W, Mesquita HM, Vargas AP. Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients: a transcranial Doppler study. Cephalalgia. 2006;26:934-939.
34. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart. 2005;91:1173-1175.
35. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59:17-20.
36. Di Tullio MR, Sacco RL, Venketasubramanian N, Sherman D, Mohr JP, Homma S. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke. 1993;24: 1020-1024.